Le Lézard
Classified in: Business
Subject: ANNUAL MEETINGS

Origin Gold Announces Results of Annual Meeting of Shareholders and Amendment to Stock Option Plan


MONTREAL, June 19, 2019 (GLOBE NEWSWIRE) -- Origin Gold Corporation ("Origin or the "Corporation") (TSX VENTURE: OIC) is pleased to announce that at the Annual Meeting of Shareholders (the "Meeting") held on June 18th, 2019 in Montreal, Canada, the nominees listed in the Information Circular dated May 14, 2019 were elected to serve as directors of the Corporation for the ensuing year.

The shareholders of the Corporation voted in favour of the two items put forward by management.

a) Messrs. Jacques Authier, Jean Depatie, Rejean Gosselin, Guy Lord and Gaetan Martel, were elected as directors;

b) Shareholders also voted in favour of appointing Raymond Chabot Grant Thornton LLP, as auditors of the Corporation for the ensuing year and authorizing the directors to fix their remuneration.

A total of 20.5 million Origin common shares were voted, representing approximately 43% of total shares issued and outstanding as at the record date of the meeting.

Following the Meeting, the board appointed Jean Depatie as Chairman of the Corporation; and Rejean Gosselin (President and CEO) and Vatche Tchakmakian (CFO and Corporate Secretary) as officers of the Corporation.

Amendment to Stock Option Plan

Origin Board of Directors has authorized an amendment to its Stock Option Plan (the "Plan") to increase to 5,000,000 the maximum number of options issuable under the Plan (which represents 9.84% of the issued and outstanding common shares of the Corporation), subject to the approval of the TSX Venture Exchange.

Following regulatory approval, the Corporation will have 1,100,435 available options for future grants under the Plan.

About Origin
Origin is a mineral exploration company with its exploration activities focused in Colombia.

The information set forth in this press release includes certain forward-looking statements. Such statements are based on assumptions exposed to major risks and uncertainties. Although Origin deems the expectations reflected in these forward-looking statements to be reasonable, the Corporation cannot provide any guarantee as to the materialization of the expectations reflected in these forward-looking statements. The Corporation expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: